Ciloxan

— THERAPEUTIC CATEGORIES —
  • Ocular infections

Ciloxan Generic Name & Formulations

General Description

Ciprofloxacin (as HCl) 0.3%; oph. soln; contains benzalkonium chloride.

Pharmacological Class

Quinolone.

See Also

How Supplied

Soln—5mL; Oint—3.5g

Ciloxan Indications

Indications

Susceptible infections of conjunctiva and cornea.

Ciloxan Dosage and Administration

Adults and Children

Conjunctivitis: 1–2 drops in conjunctival sac(s) every 2 hours while awake for 2 days, then 1–2 drops every 4 hours while awake for next 5 days. Corneal ulcers: 2 drops every 15 minutes for 1st 6 hours, then 2 drops every 30 minutes for rest of 1st day; 2nd day: 2 drops every 1 hour; 3rd–14th days: 2 drops every 4 hours. May treat for 14 days or until corneal re-epithelialization occurs.

Ciloxan Contraindications

Not Applicable

Ciloxan Boxed Warnings

Not Applicable

Ciloxan Warnings/Precautions

Warnings/Precautions

CNS or convulsive disorders. Discontinue if rash occurs. Pregnancy (Cat.C). Nursing mothers.

Ciloxan Pharmacokinetics

See Literature

Ciloxan Interactions

Interactions

May increase theophylline levels. May potentiate oral anticoagulants. May increase renal toxicity with cyclosporine.

Ciloxan Adverse Reactions

Adverse Reactions

Soln: Burning, crystalline precipitates, lid margin crusting, scales, foreign body sensation, pruritus, conjunctival hyperemia, bad taste. Oint: ocular discomfort, blurred vision; may delay corneal healing. Both: superinfection.

Ciloxan Clinical Trials

See Literature

Ciloxan Note

Not Applicable

Ciloxan Patient Counseling

See Literature